Next Article in Journal
Biodegradable Materials and Metallic Implants—A Review
Next Article in Special Issue
In Vitro Findings of Titanium Functionalized with Estradiol via Polydopamine Adlayer
Previous Article in Journal / Special Issue
The Effect of RANKL/OPG Balance on Reducing Implant Complications
Article Menu

Export Article

Open AccessArticle
J. Funct. Biomater. 2017, 8(4), 43;

Suitability of EGCG as a Means of Stabilizing a Porcine Osteochondral Xenograft

Agricultural & Biological Engineering, Mississippi State University, Mississippi State, MS 39762, USA
Author to whom correspondence should be addressed.
Received: 27 August 2017 / Revised: 14 September 2017 / Accepted: 19 September 2017 / Published: 23 September 2017
(This article belongs to the Special Issue Orthopaedic Biomaterials, Implants and Devices)
Full-Text   |   PDF [1924 KB, uploaded 23 September 2017]   |  


As a non-crosslinked osteochondral xenograft would be mechanically inferior to native cartilage and vulnerable to premature degradation, we seek a safe and effective method of xenograft stabilization. The purpose of this study was to evaluate the capacity for epigallocatechin gallate (EGCG) to stabilize a decellularized porcine osteochondral xenograft through collagen crosslinking. Our objectives were to assess the effects of EGCG on the degree of crosslinking, mechanical properties, collagenase resistance, cytotoxicity, and in vitro biocompatibility. EGCG is a green tea polyphenol that acts as a collagen crosslinker. Porcine osteochondral plugs were decellularized and then crosslinked by soaking in EGCG. The degree of crosslinking, cartilage compressive stiffness, cartilage-bone interface strength, coefficient of friction, and residual mass after collagenase exposure all increased with an increasing EGCG concentration. With the exception of the coefficient of friction, EGCG treatment could restore mechanical properties to levels equal to, or exceeding those, of native cartilage. EGCG treatment profoundly increased the enzymatic resistance, and 1% EGCG provided protection equivalent to 1% glutaraldehyde. EGCG up to 0.5 mM was essentially not cytotoxic to chondrocytes embedded in alginate, and autologous chondrocytes attached to decellularized, EGCG-fixed cartilage were all viable five days after seeding. Results demonstrate that EGCG has many beneficial effects on a decellularized osteochondral xenograft, and may be suitable for use in stabilizing such a graft prior to implantation for the repair of a defect. View Full-Text
Keywords: osteochondral xenograft; epigallocatechin gallate; crosslinking osteochondral xenograft; epigallocatechin gallate; crosslinking

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Elder, S.; Clune, J.; Walker, J.; Gloth, P. Suitability of EGCG as a Means of Stabilizing a Porcine Osteochondral Xenograft. J. Funct. Biomater. 2017, 8, 43.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
J. Funct. Biomater. EISSN 2079-4983 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top